ANI Pharmaceuticals, Inc. (ANIP)
82.75
+1.41
(+1.73%)
USD |
NASDAQ |
Dec 09, 14:03
ANI Pharmaceuticals Total Liabilities (Quarterly): 902.34M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 376.73M |
| Arcutis Biotherapeutics, Inc. | 212.90M |
| Intellia Therapeutics, Inc. | 176.85M |
| Beam Therapeutics, Inc. | 345.08M |
| Halozyme Therapeutics, Inc. | 1.717B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.408B |
| Shareholders Equity (Quarterly) | 505.82M |
| Debt to Equity Ratio | 1.249 |
| Current Ratio | 2.581 |
| Net Debt Paydown Yield | -3.12% |